66938-86-1Relevant articles and documents
A catalytic hydrogenation preparing high-purity (3,4-diamino-phenyl) (4-fluoro phenyl) ketone method
-
Paragraph 0023, (2017/02/28)
The invention relates to a method for preparing high-purity (3,4-diaminophenyl)(4-fluorophenyl) ketone by virtue of catalytic hydrogenation, belonging to the technical field of pharmaceutical and chemical engineering. The method comprises the following steps: adding (4-amino-3-nitrophenyl)(4-fluorophenyl) ketone (I) and a catalyst into an organic solvent, introducing hydrogen, and performing hydrogenation reduction reaction to obtain a flubendazole intermediate namely (3,4-diaminophenyl)(4-fluorophenyl) ketone (II). The method disclosed by the invention has the advantages that compared with a reduction method using sodium hydrosulfide, the method is simple in process, small in solvent dosage and short in reaction time, can be used for solving the problem that a large amount of sulfide-containing wastewater is difficult to be treated, and is beneficial for industrial production; meanwhile, a novel catalyst preparation method is simple, and has the characteristics of high reaction activity, good selectivity and recycled catalyst; compared with a pure Pt/C catalyst, the novel catalyst can be used for effectively inhibiting the phenomenon that carbanyl groups are reduced into methylene and inhibiting the occurrence of the defluorination phenomenon, and is relatively high in product yield and purity.
Anti-viral compounds
-
, (2008/06/13)
The present application provides a series of benzimidazole compounds which inhibit the growth of picornaviruses, such as rhinoviruses, enteroviruses, polioviruses, coxsackieviruses of the A and B groups, echo virus and Mengo virus and flaviviruses such as hepatitis C and bovine diarrheal virus.
Synthesis, antiviral activity, and biological properties of vinylacetylene analogs of enviroxime
Victor, Frantz,Brown, Thomas J.,Campanale, Kristina,Heinz, Beverly A.,Shipley, Lisa A.,Su, Kenneth S.,Tang, Joseph,Vance, Lori M.,Spitzer, Wayne A.
, p. 1511 - 1518 (2007/10/03)
A series of vinylacetylene analogs of Enviroxime (1) was synthesized. The new compounds are potent inhibitors of poliovirus in tissue culture. Cross-sensitivity with Enviroxime-derived mutants shows that the new compounds have the same mechanism of action as Enviroxime, which involves the viral 3A protein. In studies with Rhesus monkeys, the p-fluoro derivative 12 was found to be unique in providing oral bioavailability. Metabolism studies using hepatic microsomes suggest that this procedure would be a useful in vitro method for selecting the appropriate animal model for testing oral absorption. Compound 12 was found to be efficacious by oral administration in treating a Coxsackie A21 infection in CD-1 mice.